



DNA-Barcoded Fluorescence Microscopy for Spatial Omics
Florian Schueder, Eduard M. Unterauer, Mahipal Ganji, and Ralf Jungmann*
Innovation in genomics, transcriptomics, and proteomics research has
created a plethora of state-of-the-art techniques such as nucleic acid
sequencing and mass-spectrometry-based proteomics with paramount impact
in the life sciences. While current approaches yield quantitative abundance
analysis of biomolecules on an almost routine basis, coupling this high
content to spatial information in a single cell and tissue context is challenging.
Here, current implementations of spatial omics are discussed and recent
developments in the field of DNA-barcoded fluorescence microscopy are
reviewed. Light is shed on the potential of DNA-based imaging techniques to
provide a comprehensive toolbox for spatial genomics and transcriptomics
and discuss current challenges, which need to be overcome on the way to
spatial proteomics using high-resolution fluorescence microscopy.
1. Introduction
In order to understand the most fundamental principles of life,
researchers have strived to develop novel techniques to detect,
quantify, and spatially visualize interactions of proteins and nu-
cleic acids on the level of single molecules in cells, tissues, and
organisms using fluorescence microscopy. While current state-
of-the-art single-molecule techniques offer unprecedented sen-
sitivity to detect interactions of biomolecules,[1] they are usually
limited to detect only a few molecular species at a time. Com-
plexity of biological functions and processes inherently scales
with the number of molecules involved, thus visualizing the in-
teractions of just a handful of molecular species is insufficient
to understand life’s full complexity. In contrast, high content
and quantitative abundance analysis of molecular species can be
achieved using omics-type approaches such as genomics, tran-
scriptomics, or proteomics. However, the spatial resolution of
these techniques is rather limited.
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Genomics and transcriptomics research
techniques can be subdivided into de
novo – for example, sequencing-based
–readouts, providing relatively unbiased
high-content information, or the anal-
ysis of known sequence motifs using
nucleic acid probes developed to quan-
tify the occurrence of these motifs in a
relative or absolute fashion.[2,3] In pro-
teomics research, a powerful quantifi-
cation approach is mass spectrometry
(MS), which allows to determine compo-
sition, stoichiometry, and topology of pro-
tein complexes.[4] These tools are well-
suited for quantitative analysis. However,
due to their workflow, which is tradi-
tionally based on the extraction of tar-
get molecules from cells or tissues, the
spatial information provided by these assays is limited. To under-
stand many cellular functions, spatial information is essential to
put molecular abundance into the spatial context of a biological
system in situ.With an ideal tool, it would be possible to detect all
of these proximity interactions involved in cellular function with
respect to their spatial location within a single cell and beyond.
In this review, we will focus on DNA-barcoded fluorescence
microscopy for spatial omics. We discuss the potential of fluores-
cence microscopy as a future key player in spatial omics.
2. Current Approaches to Spatial Proteomics
While MS-based approaches are typically known for their capa-
bilities in quantitative abundance analysis, they can also pro-
vide spatial information. One example of this regard is fraction-
ated organelles post-lysis and protein–protein interaction net-
work analysis.[5] Another exemplary approach uses antibodies for
affinity purification of target proteins (called “baits”) and their re-
spective binding partners, followed by MS analysis.[5]
While these approaches provide a measure for spatial proxim-
ity, they are not capable of obtaining absolute spatial positions of
proteins in single cells. In order to achieve this, cytometry-based
imaging methods were developed (Figure 1a). Here, proteins of
interest are stained with metal-labeled antibodies in tissue sec-
tions before they are subjected to either imaging mass cytometry
(IMC)[6] or multiplexed ion beam imaging (MIBI)[7] for down-
stream analysis. In IMC, a high-resolution laser ablation system
is used to transfer tissue material voxel-by-voxel into a cytometry
by time-of-flight (CyTOF) mass cytometer to analyze the protein
expression levels via metal isotope content (Figure 1b). In MIBI,
an ion beam is used to scan over the tissue, generating secondary
ions containing the metal isotopes bound to the antibodies. Us-
ing a sector mass spectrometer, the content of metal isotopes,
and consequently protein expression levels are determined.
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Figure 1. Cytometry-based imaging methods. a) Imaging mass cytometry. Tissue sections are stained by multiple, distinct metal-labeled antibodies. In
cytometry by time-of-flight (CyTOF) imaging, laser ablation is used to obtain tissue sections, which are subsequently analyzed by CyTOF-MS to determine
metal isotope content and thus epitope expression. In multiplexed ion beam imaging, a primary ion beam is used to raster over the tissue to generate
secondary ions, among them the metal isotopes that were bound to the antibodies. A sector field mass spectrometer is then used to determine the
metal isotope content and the associated epitope expression in each rastered area. Adapted with permission.[8] Copyright 2016, Elsevier. b) Workflow
of imaging mass cytometry. After multiplexed metal-modified antibody labeling, the tissue is ablated in a voxel-style fashion and subsequently analyzed
by a CyTOF mass cytometer. Combining the spatial information from the ablation process with the protein identity obtained from the CyTOF step, a
spatially resolved, multiplexed “image” for up to 44marker proteins is obtained, readying the data for downstream single-cell segmentation and analysis.
Adapted with permission.[6] Copyright 2014, Springer Nature.
Although cytometry-based imaging methods can provide abso-
lute spatial resolution and target multiplexing, they are currently
limited by the precision of laser ablation and ion beammilling to
about 200 nm spatial resolution.[8] Multiplexing in current imple-
mentations is limited due to the dependence on metal-modified
antibodies to 44-plex.[8] Furthermore, the use of antibodies poses
potential issues in terms of target labeling efficiency, specificity,
and spatial accessibility, limiting quantitative analysis.
3. Fluorescence Microscopy as Potential Tool for
Spatial Omics
While technical approaches described above provide exquisite
high-content information, they struggle to obtain spatial infor-
mation. To label and localize biomolecules in an absolute spatial
context of complex cell and tissue environments, fluorescence
tagging and imagingmodalities such as fluorescencemicroscopy
have been the major workhorses in life science research.[9,10] Its
popularity is mainly based on three pillars: 1) relatively high spa-
tial resolution, 2) multiplexed detection using spectrally distinct
fluorophores, and 3) target specificity due to the ubiquitous avail-
ability of labeling reagents such as antibodies for proteins and
DNA-based probes for nucleic acids, respectively.
However, if fluorescence microscopy ought to become a uni-
versally applicable spatial omics tool, these unique advantages
are also its biggest achilles heel. First, the resolution of a con-
ventional light microscope is limited by the diffraction of light
to about 200 nm laterally and 500 nm axially,[11] preventing
diffraction-limitedmicroscopy to resolve singlemolecules in cells
and tissues with high target densities. Second, multiplexing of
different molecular species is severely limited by the relatively
broad emission spectrum of fluorophores, preventing the sepa-
ration of more than about four dye-labeled species in the visible
spectrum.[11] Third, there is a specific need to label molecules
with binders, creating issues in terms of specificity, binder size,
and labeling efficiency. In an ideal scenario, where fluorescence
microscopy would become the prime tool for spatial omics, its
resolution should be improved to the size of single proteins
(e.g., 5 nm or better spatial resolution), multiplexing capabilities
be enhanced to hundreds or even thousands of target species,
and small efficient high-performance labeling reagents be
developed.
To pave the route for spatial omics with fluorescence mi-
croscopy, researchers have started to make use of the sequence
programmability of nucleic acids to develop DNA-barcoded
imaging probes for improving the multiplexing aspect in fluo-
rescence microscopy. We here focus on different strategies for
DNA, RNA, and protein multiplexing using DNA-based labeling
probes. These approaches can further be combined with state-of-
the-art super-resolutionmodalities,[12–15] technically approaching
spatial resolutions of better than 5 nm.[16–18]
4. Multiplexed Protein Detection Using Sequential
Labeling and Fluorescence Imaging
Some of the earliest implementations of spectrally unlimited
multiplexing use sequential antibody labeling, imaging, and re-
moval of the antibody. Several studies have applied this approach
for multiplexed imaging in formalin-fixed tissues and cultured
cells.[19,20] In multiplexed cyclic immunofluorescence imaging,
by repeated staining cycles of fluorophore-conjugated antibod-
ies against two antigens, two-channel imaging, and extinguish-
ing the fluorescence by chemical treatment, 61-plex imaging was
achieved.[21] In an extension of this technique, called tissue-based
cyclic immunofluorescence microscopy, four-channel imaging
was implemented.[22] By iterative fluorophore-conjugated anti-
body labeling, four-channel fluorescence imaging, and extin-
guishing fluorescence, 60-plex images were obtained. Lately,
there have been efforts to automate[23] sequential multiplexed
super-resolution microscopy in order to routinely achieve >10
target multiplexing.
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Figure 2. DNA-based multiplexing in fluorescence microscopy. a) Multiplexed in situ immunofluorescence labeling and sequential imaging of proteins
using dynamic DNA complexes. The target strand (TS) is conjugated to an antibody against a protein of interest. Upon incubation of the sample with
the probe complex (PC), the reporting complex (IR) is formed, unquenching the fluorescent dye, which is subsequently imaged. Post acquisition, an
eraser strand (E) is incubated, which in turn removes the dye-labeled strand via toehold-mediated strand displacement from the target, concluding one
imaging round. Next, another protein species can be labeled by introducing another set of probe complexes, repeating the imaging procedure. Adapted
with permission.[25] Copyright 2012, Wiley. b) Co-detection by indexing (CODEX). Antibodies against targets of interest are labeled with a unique,
rationally designed oligonucleotide duplex. In each cycle, they are extended by one out of two non-fluorescent indexing nucleotides (A or G), filling the
index position across all antibodies. Exactly two DNA duplexes (and thus two target proteins) are furthermore fluorescently labeled by either Cy3 or Cy5
dyes based on their designed sequence, enabling their detection by fluorescence microscopy. Post-acquisition, the dyes are cleaved and washed away.
The whole process is then repeated until all targets are visualized. Adapted with permission.[29] Copyright 2018, Elsevier. c) DNA-based multiplexing
in super-resolution microscopy by Exchange-PAINT. Target species are simultaneously labeled with orthogonal, single-stranded DNA molecules (called
“docking” strands). In the first round, a fluorescently labeled DNA oligo (termed “imager”), complimentary to the docking strand on the first target,
is introduced and DNA-PAINT image acquisition is performed (see text for more details). Post acquisition, the transiently binding imager strands
against the first target are washed out and imagers (carrying the same spectral dye) complementary to the second target strand are introduced. This
process is then repeated iteratively until every target species is imaged. Adapted with permission.[17] Copyright 2017, Springer Nature. d) Exemplary
ten-target in vitro Exchange-PAINT experiment on DNA origami structures, representing digits 0 to 9. Adapted with permission.[34] Copyright 2014,
Springer Nature. e) Extension of the exchange concept to all fluorescence imaging modalities. Targets are labeled with orthogonal 12 nucleotide long
DNA sequences, leading to quasi-stable imager-docking complexes. After hybridization, all probe strands remaining in solution are washed out and
imaging is performed subsequently. Next, a washing buffer (containing formamide) is introduced to dissociate the probe strands from the target of
interest. Finally, the washing buffer and the now diffusing probe strands are replaced by a labeling buffer, and the whole process is repeated until all
target signals are acquired. Adapted with permission.[36] Copyright 2017, Wiley. Scale bar: 25 nm (d).
5. DNA-Barcoded Fluorescence Microscopy for
Highly Multiplexed Protein Imaging
While cyclic immunofluorescence imaging—as described
above—theoretically allows for unlimited multiplexing, there
is a practical limit, as labeling, imaging, and dye inactivation
is a time-consuming procedure, taking up to 24 h per imaging
round.[21,22,24] DNA-based labeling and imaging approaches can
be used to overcome this limitation. As a first example, we will
discuss approaches from Michael Diehl’s lab, who use dynamic
DNA complexes to achieve multiplexed protein detection in
cells, not limited by the use of spectrally distinct fluorophores or
sequential staining procedures.[25–27] In their approach, multiple
antibodies against different proteins of interest are conjugated
with orthogonal single-stranded DNA molecules (called target
strands), such that each target antibody carries a unique DNA
barcode (Figure 2a). Post-fixation, cell samples are labeled with
this antibody mix (simultaneously, rather than sequentially).
Prior to image acquisition, a “probe complex” is flushed in,
consisting of three DNA strands, where one carries a dye and
another strand a quencher molecule, preventing fluorescence
from the dye. By a toehold-mediated strand displacement
reaction,[28] in which a single-stranded sequence extension is
used as a nucleation motif for the target strand, the dye-labeled
strand can be displaced from the probe complex (forming the
“reporting complex”). This separates the dye from the quencher
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strand, which (as an “output”) can diffuse into the solution and
eventually be washed away. In the next step, the reporting com-
plex on the first species of interest can be visualized via classical
fluorescence microscopy. Post-acquisition, an eraser stand is
introduced, which displaces the fluorescently labeled strand
from the target, forming a “waste complex”. After washing out
the waste complex, the system is in the initial state and the
process can be repeated iteratively for all remaining targets. It is
of importance to note that this sequential labeling and imaging
approach also overcomes the limitation of spectral multiplexing,
as in each round the same spectral dyes (e.g., three species per
round) can be reused in subsequent rounds.
Another implementation that makes use of DNA-conjugated
antibodies formultiplexed protein imagingwith fluorescencemi-
croscopy is called co-detection by indexing (CODEX), developed
by Garry Nolan’s lab.[29] In CODEX (Figure 2b), the DNA barcode
strands are hybridized with complementary “primer” strands.
In the first round, the primer on the protein to be imaged is
extended by a DNA polymerase with a single dye-labeled nu-
cleotide. Simultaneously, the DNAbarcode on the protein species
to be imaged in the second round is extended by a nucleotide.
Post-acquisition of round one, the fluorophore is extinguished.
By repeating primer extension, imaging, and inactivation of the
fluorophore, CODEX was thus far able to acquire as many as
22 different proteins of interest in mouse-isolated splenocyte
cells.
6. DNA-Based Super-Resolution Microscopy
As discussed before, in the most ideal implementation of spa-
tial omics by fluorescence microscopy, the resolution should
approach the size of single proteins. To circumvent the classical
diffraction limit in fluorescence microscopy, super-resolution
techniques have been invented.[12–14] One prominent approach
is called single molecule localization microscopy (SMLM),[30,31]
where super-resolution is achieved by spatiotemporal separation
of single-molecule emission and subsequent sub-diffraction
localization. In DNA points accumulation in nanoscale topog-
raphy (DNA-PAINT),[32] the necessary switching between ON-
and OFF-states is achieved by diffusion and transient binding
of short dye-labeled oligonucleotides (called “imager” strands)
to their respective target-bound complementary strands (called
“docking” strands). To implement DNA- or Exchange-PAINT for
imaging cellular targets such as proteins, typically antibodies,
nanobodies, or small molecules binders such as phalloidin for
actin imaging are functionalized with DNA-PAINT docking
sequences using standard biochemical conjugation assays.[33] As
dye-labeled imager strands bind only transiently to their targets,
spectrally unlimited multiplexing by sequential imaging of com-
plementary target strands can be achieved by using the unique
sequence specificity of DNA molecules. This concept is called
Exchange-PAINT[34] (Figure 2c). Here, different target species
are labeled with orthogonal, single-stranded DNA molecules.
For imaging of the first target, the imager complementary to the
docking strand bound to this first target is washed in. After im-
age acquisition, the imager strands are washed out and a second
imager species, complementary to docking strands bound to the
second target are introduced. This process is then repeated until
all target species are imaged. Figure 2d presents exemplary DNA
origami in vitro data for ten-target Exchange-PAINT. Each digit
represents one unique DNA origami species.
In DNA origami,[35] a long single-stranded DNA molecule
(called “scaffold,” usually derived from the genome of the bac-
teriophage M13mp18) is folded into a pre-designed shape by
≈200 short, complementary strands called “staples.” Each staple
specifically binds parts of the scaffold together in a thermal an-
nealing process, folding the scaffold into the prescribed shape.
These structures represent a unique class of self-assembled,
fully addressable 12 × 18 pixel-sized “nano-breadboards,” where
“pixels” (i.e., single staple strands) are spaced 5 nm apart and can
be designed to carry specific docking strands.[17] For applications
where DNA origami structures are employed to label and detect
nucleic acid sequences (such as, e.g., mRNA), origami can be
equipped with unique single-stranded extensions, which can, for
example, bind to specific RNA sequences. For protein detection,
DNA- or RNA-based aptamers can be employed.
In Exchange-PAINT, similar to the DNA-barcoded imaging ap-
proaches discussed above, multiplexing capacity is only limited
by the number of orthogonal DNA sequences (fulfilling certain
criteria for binding kinetics compatible with DNA-PAINT). How-
ever, while approaches from Diehl and Nolan are relatively time
consuming (i.e., involve several steps for target activation and in-
activation), image acquisition in Exchange-PAINT is comparably
fast, as dye-labeled strands only transiently bind their targets and
are thus easily replaced by a simple buffer exchange reaction,
which can be as fast as a few tens of seconds.
The concept of Exchange-PAINT was later generalized to
other super-resolution and diffraction-limited techniques.[36]
Here, the imager/docking strand duplex is designed to yield a
stable, rather than transient interaction (Figure 2e). This virtually
“labels” the target with a “fixed” dye strand. Post image acquisi-
tion, the dye-labeled strand is forced to dissociate from the target
using a low salinity, formamide-containing washing buffer,
which reduces the melting temperature of the duplex.[37,38]
Finally, the washing buffer and the now unbound dye-labeled
strands are replaced by the incubation buffer and the whole
process is repeated until all targets are imaged. This concept,
termed Universal Multiplexing by DNA Exchange, now brings
DNA-barcoded and thus theoretically unlimited multiplexing to
virtually any fluorescence imaging modality.
7. Spatiospectral Barcoding Using Designer DNA
Probes
While the aforementioned DNA-barcoded multiplexing ap-
proaches enable spectrally unlimited imaging, acquisition time
increases linearly with the number of target species. While this
is of no concern for a few tens of targets, acquisition times be-
come prohibitively long for hundreds or even more species. One
way to improve the rather simple sequential imaging approach is
the combination with prescribed spatial or spectral information
(or both).
One exciting implementation of a geometrically encoded bar-
code is shown in Figure 3a. Here, mRNA species are hybridized
with fluorophore-conjugated complementary single-stranded
DNA molecules and imaged with fluorescence microscopy, a
technique called single-molecule fluorescence in situ hybridiza-
tion (smFISH). The length of the mRNA molecule allows for
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Figure 3. DNA-based combinatorial multiplexing. a) Spatiospectral barcoding for imaging a large number of nucleic acids. Schematics showing two RNA
species labeled with three spectrally distinct fluorophores using a prescribed spatial arrangement. Based on the 2D-position of each of the fluorophores
on a given RNAmolecule, species can be identified. Adapted with permission.[39] Copyright 2012, Springer Nature. b) Self-assembledDNA origami-based
spatiospectral barcodes (top left) visualized using Exchange-PAINT super-resolutionmicroscopy (5 exemplary barcodes shown on the bottom left) enable
sub-diffraction-sized barcoding for up to several thousand targets. Adapted with permission.[40] Copyright 2012, Springer Nature. c) Engineered binding
kinetics for DNA-PAINT super-resolution imaging enables multiplexing of multiple RNA species. Two frequency barcodes are used in a proof-of-concept
visualizing MKI67 and TFRC mRNA molecules. Based on the unique frequency of each RNA molecule obtained from a kinetic histogram analysis, a
pseudo-color is assigned to eachmolecule. Adapted with permission.[41] Copyright 2019, American Chemical Society. d) Combinatorial multiplexing with
sequential FISH (SeqFISH, exemplary codebook). The mRNA target is sequentially imaged by direct hybridization of a specific fluorophore conjugated
to target-complementary DNA probes. By DNase I-catalyzed removal of the complements and subsequent hybridization of a new dye-labeled probe, a
sequence-specific barcode can be assembled for each molecule of interest. e) Representative data showing two rounds of imaging in SeqFISH. Adapted
with permission.[42] Copyright 2014, Springer Nature. Scale bars: 250 nm (b), 1 µm (c), 1 µm (e, inset).
the hybridization of several short DNA oligomers. This enables
combinatorial labeling using spatially resolved barcodes. By
implementing smFISH on mRNA species in Saccharomyces
cerevisiae, Lubeck et al. performed multiplexed imaging by
encoding the multi-target information in a spatial barcode.[39] In
order to resolve sub-wavelength distances, these spatial barcodes
were combined with orthogonal spectral information, enabling
the identification of individual positions on sub-diffraction-sized
RNA molecules. While spatial barcodes in principle represent a
powerful and intuitive way to reach a high multiplexing capacity,
the approach is hindered by relatively demanding requirements
with regard to resolution in order to faithfully decode spatial
information. More relaxed requirements are faced when imple-
menting spectral barcodes. Using seven photoswitchable dyes
and three dyes per barcode, Lubeck et al. were able to multiplex
32 mRNA species in a single round of imaging.
To overcome the possible ambiguity of spatial barcodes on
flexible mRNA targets, recently developed self-assembled DNA
origami structures can be employed as a solution to provide geo-
metrically encoded labels (Figure 3b). Using 6-helix bundle struc-
tures, Lin et al. were able to use the unique spatial address-
ability and molecular stiffness of these structures to create sub-
diffraction-sized spatiospectral barcodes consisting of, for exam-
ple, five spatial positions, which can be “labeled” with either a
blue, green, or red fluorophore, theoretically allowing for ap-
prox. 2400 barcode species (Figure 3b).[40] These nanobarcodes
could, for example, be used for ex situ mRNA detection from
cell lysates by modifying the DNA nanostructures with single-
stranded capture sequences, complementary to an mRNA se-
quence of interest. Using seven spatial positions, the multiplex-
ing capacity can be increased to theoretically over 800 000 possi-
ble targets, covering the transcriptomemultiple times over.While
this represents an exciting advance, the DNA origami-based spa-
tial barcodes are only really applicable in ex situ imaging appli-
cations. The main reason for this is that—albeit nanoscale in
size—the structures are still approximately 400 nm in length,
preventing their applicability to target biomolecules in situ inside
cells.
An entirely orthogonal approach for multiplexed, barcoded
microscopy can be achieved by using the predictable, well-
understood hybridization kinetics in DNA-PAINT microscopy to
rationally design the blinking behavior (e.g., fluorescence ON-
and OFF-times) of targets with engineered binding frequency
and duration (Figure 3c).[41] This general concept uses the fact
that a target exhibiting, for example, five DNA-PAINT binding
sites compared to a target with one shows a five times higher
blinking frequency. If these two frequency levels could be distin-
guished, they can then be used as a barcode. Figure 3c shows
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a proof-of-concept implementation of such a frequency barcode
using smFISH targeting two mRNA target species inside a cell.
Here, the probe set against theMKI67mRNA contains three con-
catenated binding sites per probe, while the set targeting TFRC
contains only one binding site per probe. This can further be
combined with a binding duration barcode (e.g., distinguishing
the binding time and thus blink duration of a 9 versus 10 bp du-
plex) and spectral colors to considerably increase the amount of
simultaneous detectable species (e.g., assuming four frequency
levels and three spectral colors, one could acquire 124 target
species simultaneously).
8. Genome-Scale Spatial Omics with Multiplexed
Combinatorial Imaging
With the technical capability on the horizon to image hundreds
or an even larger number of targets simultaneously in a sin-
gle cell, target density becomes an increasingly severe prob-
lem, even for super-resolution implementations. When imaging
a sparsely populated target, like in the case of the S. cerevisiae
where all targetedmRNA species only occupied 2% of the cell vol-
ume, distinguishing signals from individual targets is relatively
straightforward.[39] But for the case of a much more densely pop-
ulated environment (or higher plex readout), individual species
cannot be resolved. An elegant solution to this issue is to tar-
get only a subset of all targets in one imaging round. Instead of
imaging all probes at once, the hybridized complements are dis-
placed after a single imaging round byDNAse I treatment and the
next subset of probes is hybridized. This introduces a sequential
imaging pattern (SeqFISH),[42,43] in which the target is encoded
by “positive” and “negative” readouts, a binary code (Figure 3d).
These codes can then be visualized in a codebook, showing either
all readout rounds (“positive” or “negative”) or only the “positive,”
so called “barcoding” rounds. With this approach, it is possible
to image FN probes with F being the number of different fluo-
rophores in a single round and N the total number of barcoding
rounds (exemplary data, Figure 3e). By replacing the fixed dye
on the FISH probes with a single-stranded overhang,[44] a sec-
ondary, dye-labeled complement can be hybridized, furthermore
decoupling the “positive” readout signal from spectral colors as
in Exchange-PAINT[34] and Universal Exchange.[36] When oper-
ating in densely populated environments, image correlation can
be combined with the barcoding system to yield quantification
even without single spot resolution.[45]
In a recent study, Eng et al. have shown that by using 60 such
pseudocolors, they could image 10 000 mRNA species in mouse
brain tissues (SeqFISH+).[46] In their barcoding approach, they
separated the targets into three fluorescent channels and imaged
20 sequential rounds for each color channel, completing one su-
perordinate barcoding round. Each target appears in exactly one
of these 20 readout rounds. A total of four overarching barcoding
rounds would theoretically allow for imaging 204 targets per fluo-
rescent color, so in total an impressive number of 480 000 unique
barcodes (Figure 4a).
With the complexity of barcodes rising, the inevitable ques-
tion is: How error-prone is the coding strategy? In the case of
SeqFISH, one additional round of imaging with specific targets
was used to check for the most likely error, which is missing a
hybridization event,[47] as a re-occurrence of misidentifications
should be unlikely due to the use of DNAse I as “quencher.”
While this approach serves as an easy-to-implement and fast cor-
rection, another technique has set out to use “perfect codes” for
the introduction of an error-robust encoding scheme to correct
for a larger variety of possible error modes. In Multiplexed Error-
Robust FISH (MERFISH),[48] Chen et al. have developed a code-
book in which every target is encoded by a 16-bit binary barcode
(Figure 4b). Using 16 rounds of imaging, the possible number
of targets is 216 − 1 = 65 535, yet misidentification and missing
errors scale with the number of imaging rounds. This problem
was solved by using a concept from information theory, called the
Hamming distance (HD). Here, each barcode is separated from
all others by at least four changes in binaries (HD4-code). This
allows for the correction of one-bit errors and for the identifica-
tion of two-bit errors. Furthermore, Chen et al. set the numbers
of positive readouts per single barcode to four. With this decrease
in positive readout bits, the signal per single round of imaging is
kept low and it also accounts for the higher likelihood of miss-
ing a positive event (1→ 0) than misidentification of background
spots (0 → 1). Nevertheless, with these boundaries, the number
of targets drastically decreases from 65 535 to 140. By moving
from an HD4- to an HD2-code, error-correction is lost (yet de-
tection still possible), but in 14 rounds of imaging, Chen et al.
were able to image 1001 mRNA targets. In a recent study, MER-
FISH was combined with expansion microscopy to image 10 000
mRNA targets using a 69-bit HD4 code with three colors and 23
rounds of hybridization and imaging.[49]
Apart frommultiplexing differentmRNA species, it is also pos-
sible to use the specificity of FISH to address multiplexed super-
resolution imaging of chromosome conformation. Since the
structural organization of chromatin is typically investigated by
Hi-C approaches, providing ensemble average information with-
out visualization, detailed high-resolution images from single-
cell chromatin sub-structures are missing. Furthermore, chemi-
cal cross-linking is blind to physically separated fragments, thus
preventing Hi-C to capture interactions if two fragments have
just separated. These challenges were recently solved by imple-
menting combinatorial 3D multiplexed super-resolution imag-
ing of certain chromosome regions.[50] To image a 1.2 Mb chro-
mosome region, Bintu et al. first divided it into consecutive seg-
ments of 30 kb. Each segment was then labeled with approxi-
mately 300 primary probes, to which secondary probes could be
hybridized for sequential imaging.[44] After each imaging step,
the probes were removed by either displacement or photobleach-
ing. With this approach, the authors generated contact frequency
maps for 250 chromosomes, which showed high agreement with
previous Hi-C studies for the same region and additionally pro-
vided information about single-cell variability with high spatial
resolution.
9. Outlook and Future Challenges
Zooming out, technology development on the side of spatial tran-
scriptomics and genomics using fluorescence microscopy has
yielded impressive advancements in the past years, now allow-
ing to spatially visualize hundreds to thousands of nucleic acid
species simultaneously in a single cell. Porting this unique capa-
bility to spatial proteomics would be an exciting next step, even-
tually closing the gap with MS-based proteomics techniques in
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Figure 4. Error-robust spatial transcriptomics by SeqFISH+ and MERFISH. a) High-throughput combinatorial multiplexing with SeqFISH+. mRNA
targets (1 to M) are assigned a unique code, consisting of four barcoding rounds (I to IV). The primary DNA probes consist of an RNA targeting
sequence and single-stranded extensions for hybridization of four unique secondary probes (corresponding to the four barcoding rounds). In each
barcoding round, 20 sequential labeling and readouts are performed (using three spectral colors, e.g., Alexa 488, Cy3B, Alexa 647). Each target is read
out once per barcoding round. Data is shown for 47 000 decoded RNAs per cell. Adapted with permission.[46] Copyright 2019, Springer Nature. b)
Multiplexed error robust FISH (MERFISH). Each mRNA target (1 to M) is assigned a binary barcode (16-bit in this example, using a modified Hamming
distance codebook for error detection and correction), whose length corresponds to the number of sequential labeling and readout rounds. Each target
is read out four times (corresponding to four 1 bits and twelve 0 bits). An exemplary imaging result coding for 140 RNA species in a cell is shown on the
right. Adadpted with permission.[48] Copyright 2015, American Association for the Advancement of Science. Scale bars: 10 µm (a), 100 nm (a, inset),
10 µm (b), 1 µm (b, inset).
terms of content. MS-based techniques provide the unique ad-
vantage of de novo capturing whole protein contents as it is in-
trinsically a label-free method. However, recent developments
on the side of fluorescence detection of RNA species without
the use of FISH-based labels have opened exciting new routes,
mainly fueled by the invention of the so-called fluorescence in
situ sequencing approaches, or fluorescent in situ sequencing
(FISSEQ).[51]
Translating spatiospectral combinatorial FISH-based barcod-
ing approaches or FISSEQ to proteins, however, faces similar is-
sues to the ones discussed in the imaging cytometry section of
this review, which is the lack of small, efficient, and specific la-
beling probes for a large variety of protein species. Furthermore,
while it is relatively economical and straightforward to synthe-
size and hybridize labeling probes for DNA and RNA targets,[52]
a similar universal approach is missing for labeling proteins,
which is traditionally achieved by antibodies. These can be up
to two orders of magnitude more expensive than DNA probes
in FISH experiments and especially for densely packed target
proteins, the labeling efficiency can decrease due to sterical hin-
drance caused by the relatively large size of the antibody (usu-
ally approx. 150 kDa).[53,54] Furthermore, antibodies need to be
screened for their suitability in immunofluorescence, which is a
costly, tedious, and time-consuming effort. One of the reasons
is that the fixation step (preserving the spatial state of the cell)
is usually performed prior to immunolabeling. In order to ad-
dress these difficulties and obtain improved labeling probes for
proteins, especially for super-resolution microscopy techniques,
multiple small high-affinity binders (e.g., aptamers, nanobod-
ies, and affimers) have been developed.[33,53,55–57] Latest develop-
ments in this regard are slow off-rate modified aptamers (SO-
MAmer) for DNA-PAINT.[58] SOMAmers are small (7–30 kDa),
quantitative, and versatile labeling probes and represent a unique
class of DNA aptamers that contain modified bases with hy-
drophobic residues, similar to the amino acid residues abun-
dant in antibody epitopes used for high-specificity and high-
affinity binding of proteins. These base modifications increase
the range of protein targets for which high-affinity ligands can
be selected using traditional in vitro selection procedures. Since
SOMAmers are synthetically produced, they are relatively cheap
to fabricate once a suitable binder sequence is obtained. Lately,
there have been multiple cellular applications of DNA-PAINT
exploring protein pattern distributions of, for example, cell sur-
face receptors such as members of the fibroblast growth factor
receptor family,[59] spatial distributions of epidermal growth fac-
tor receptor (EGFR) and MET receptors[60] and relative spatial ar-
rangements of EGFR, Her2, ErbB3, and c-Met receptors.[61] In
order to further improve detection of low abundance targets in,
for example, tissues with DNA-barcoded labeling reagents, re-
cently developed signal amplification methods such as immuno-
signal amplification by exchange reaction (SABER)[62] could be
employed. In immuno-SABER, single-stranded DNA concate-
mers aggregate a multitude of short complementary fluores-
cently labeled strands per DNA-barcoded affinity reagent, thus
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amplifying its signal. Furthermore, reducing the image voxel
size by super-resolution microscopy is essential for the investi-
gation of high-density targets in spatial omics. For imaging tens,
potentially hundreds of rounds, a critical aspect in this regard
is the amount of time spent for one round of imaging.[63–65]
While super-resolution methods offer high spatial resolution,
they are comparably slow. However, recently the imaging speed
of DNA-PAINT was increased by one order of magnitude by ra-
tional DNA sequence design and optimized salinity of the imag-
ing solution.[66] With further future advancements and possi-
ble combination with combinatorial barcoding schemes, spatial
proteomics by super-resolution fluorescence microscopy might
finally become a reality.
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